Brind.

Roche and Siemens Healthineers lead the ASEAN diagnostics market.

1 report, 1 independent Updated Aug 27

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Hoffmann-La Roche Siemens Healthineers

Keep exploring

The entities involved

Hoffmann-La Roche
Swiss healthcare company
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
- Hoffmann-La Roche opened a new R&D center in Boston.Sat 11:08
Siemens Healthineers
German company
- The White House threatened new tariffs on Canadian imports, highlighting the healthcare sector's reliance on integrated Canadian supply chains.Sun 07:20

Coverage

Newest first; wire copies grouped

Aug 27GlobeNewswireASEAN Point of Care Diagnostics Company Evaluation Report 2025 | Abbott, Roche, and Siemens Healthineers Lead with Leadership in Diagnostics, Personalized Care, and AI-Integrated Medical Technologies